Mounjaro PBS listing process ends after Eli Lilly steps back
The Mounjaro PBS listing process has officially ended. Eli Lilly Australia has confirmed it will not list tirzepatide, sold as Mounjaro, on the Pharmaceutical Benefits Scheme (PBS) for type 2 diabetes. The company announced the decision in April 2026, saying










